Envista Holdings Corp (NVST)

USD 18.2

(-5.41%)

EBITDA Summary of Envista Holdings Corp

Envista Holdings Corp's latest annual EBITDA in 2023 was 171.1 Million USD , down -11.35% from previous year.
Envista Holdings Corp's latest quarterly EBITDA in 2024 Q3 was 58.8 Million USD , up 105.25% from previous quarter.
Envista Holdings Corp reported an annual EBITDA of 484.4 Million USD in 2022, up 5.19% from previous year.
Envista Holdings Corp reported an annual EBITDA of 460.5 Million USD in 2021, up 135.55% from previous year.
Envista Holdings Corp reported a quarterly EBITDA of 40.3 Million USD for 2024 Q2, down -1286.86% from previous quarter.
Envista Holdings Corp reported a quarterly EBITDA of 58.8 Million USD for 2024 Q3, up 105.25% from previous quarter.

Annual EBITDA Chart of Envista Holdings Corp (2023 - 2016)

Historical Annual EBITDA of Envista Holdings Corp (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	171.1 Million USD	-11.35%
2022	484.4 Million USD	5.19%
2021	460.5 Million USD	135.55%
2020	205.6 Million USD	-29.93%
2019	447.1 Million USD	-34.87%
2018	454.8 Million USD	-15.69%
2017	508.1 Million USD	-4.13%
2016	530 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	94.4 Million USD	158.6%
2024 Q2	40.3 Million USD	-1286.86%
2024 Q3	58.8 Million USD	105.25%
2023 FY	- USD	-11.35%
2023 Q3	90.8 Million USD	-27.99%
2023 Q2	126.1 Million USD	9.37%
2023 Q1	115.3 Million USD	-12.98%
2023 Q4	-161.1 Million USD	-277.42%
2022 FY	- USD	5.19%
2022 Q4	132.5 Million USD	77.14%
2022 Q3	74.8 Million USD	-37.61%
2022 Q2	119.9 Million USD	-7.41%
2022 Q1	129.5 Million USD	171.49%
2021 Q2	136.5 Million USD	-7.21%
2021 FY	- USD	135.55%
2021 Q3	119 Million USD	-12.82%
2021 Q1	147.1 Million USD	54.03%
2021 Q4	47.7 Million USD	-59.92%
2020 Q3	112.1 Million USD	266.07%
2020 Q4	95.5 Million USD	-14.81%
2020 FY	- USD	-29.93%
2020 Q1	14.9 Million USD	-80.87%
2020 Q2	-67.5 Million USD	-553.02%
2019 Q2	109.7 Million USD	42.1%
2019 FY	- USD	-34.87%
2019 Q3	78.9 Million USD	-28.08%
2019 Q1	77.2 Million USD	-21.7%
2019 Q4	77.9 Million USD	-1.27%
2018 Q3	114.8 Million USD	-13.81%
2018 Q1	81.4 Million USD	0.0%
2018 Q2	133.2 Million USD	63.64%
2018 Q4	98.6 Million USD	-14.11%
2018 FY	- USD	-15.69%
2017 FY	- USD	-4.13%
2016 FY	- USD	0.0%

Peer EBITDA Comparison of Envista Holdings Corp

Name	EBITDA	EBITDA Difference
Alcon Inc.	2.39 Billion USD	92.85%
AptarGroup, Inc.	663.83 Million USD	74.226%
Baxter International Inc.	2.77 Billion USD	93.836%
Becton, Dickinson and Company	2.42 Billion USD	92.944%
Bausch + Lomb Corporation	586 Million USD	70.802%
Haemonetics Corporation	262.09 Million USD	34.719%
ResMed Inc.	1.6 Billion USD	89.308%
Teleflex Incorporated	792.26 Million USD	78.404%
Warby Parker Inc.	-30.21 Million USD	666.331%
West Pharmaceutical Services, Inc.	847.8 Million USD	79.818%